Table 1.
Subjects’ demographic and clinical features.
| Patients | Controls | |
|---|---|---|
| No of Individuals | 100 | 105 |
| Mean age (years) ± SD | 4.6±3.2 | 5.1±3 |
| Sex | ||
| Male | 52 (52%) | 48 (45.7%) |
| Female | 48 (48%) | 57 (54.3%) |
| CBC parameters | ||
| WBC count (x1000/ul) | 40.148±38.476 | 7.935± 0.960 |
| Hemoglobin (gr/dl) | 7.533±1.681 | 13.241±1.253 |
| PLT Count (x1000/ul) | 96.495±62.206 | 226.588±39.656 |
| Cytogenetic alterations | ||
| Hyperdiploid | 23 (23%) | ------------ |
| Hypodiploid | 3 (3%) | ------------ |
| Pseudodiploid | 28 (28%) | ------------ |
| Normal karyotype | 29 (29%) | ------------ |
| ETV6-RUNX1 (n, %) | 14 (14%) | ------------ |
| BCR-ABL | 3 (3%) | ------------ |
| AF4-MLL | 3 (3%) | ------------ |
| E2A-PBX1 | 7 (7%) | ------------ |
| Immunophenotyping data | ||
| Pro-B-ALL | 21 (21%) | ------------ |
| Early-Pre-B | 15 (15%) | ------------ |
| Pre-B-ALL | 64 (64%) | ------------ |